Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 05, 2020
HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial.
Journal: Journal of the International Association of Providers of AIDS Care
Published: February 26, 2019
Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.
Journal: AIDS research and human retroviruses
Published: June 28, 2016
Brief Report: Geographical Variation in Prevalence of Cryptococcal Antigenemia Among HIV-Infected, Treatment-Naive Patients in Nigeria: A Multicenter Cross-Sectional Study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: May 05, 2016
Long-term outcome of second-line antiretroviral therapy in resource-limited settings.
Journal: Journal of the International Association of Providers of AIDS Care
Published: December 17, 2014
Pain Management for Persons Living With HIV Disease: Experience With Interprofessional Education in Nigeria.
Journal: The American journal of hospice & palliative care
Published: April 15, 2014
Long-term outcome of second-line antiretroviral therapy in resource-limited settings.
Journal: Journal of the International Association of Providers of AIDS Care
Published: March 27, 2014
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study.
Journal: Lancet (London, England)
Published: June 18, 2013
The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa.
Journal: PloS one
Published: September 25, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026